Underutilisation of ACE inhibitors in patients with congestive heart failure.
about
Changes in heart failure medications in patients hospitalised and discharged.Optimal dosing of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: a cross-sectional study in Palestine.Gaps in Medical and Device Therapy for Patients with Left Ventricular Systolic Dysfunction: The EchoGap Study.Revascularization in patients with heart failure.High-versus low-dose ACE inhibitor therapy in chronic heart failure.Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance.Prevalence of Heart Failure and Adherence to Process Indicators: Which Socio-Demographic Determinants are Involved?Core Measures for Congestive Heart Failure in a Tertiary Care Setting in PakistanMaintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial.Practice patterns and outcomes in patients presenting to the emergency department with acute heart failure.Reasons for non-use of proven pharmacotherapeutic interventions: systematic review and framework development.Influence of sex on treatment and outcome in chronic heart failure.Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.Potentially inappropriate use of furosemide in a very elderly population: An observational study.Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II
P2860
Q33264476-D04A694A-2ABE-47FC-9C18-024CE6D138D2Q33619578-CB66C993-E312-437B-81F3-3225D8CE3F07Q34384769-FB851344-A649-4F12-A474-A8C9585B0D34Q34947268-C7C5CCD6-1936-4281-A256-D85143E22215Q35693765-29C75103-57BB-46E0-91F2-D3A9A209EBF9Q36336801-46C59809-9A27-4DCC-8B3C-F448DD80D5C8Q36633996-C938D6B2-5C50-453A-B0AE-9D169EAB7E18Q37242299-3815186C-A997-4619-97D6-34C6E453C3D8Q37275785-DAC3FEF4-6A26-4071-8197-2388B88FCC79Q37293780-A8A26D42-4B6B-4EC9-A71C-82641645A70AQ37782417-728D24C2-A5E2-429F-9AFD-C1924FC5754EQ37877792-520E6670-A132-4195-A920-68D2E052A60EQ46640341-B20D3C42-4731-489D-8C20-7181C0AD78B7Q48271585-0A57480E-92BB-4068-873C-E2E0EF182CF6Q57422693-A1E13DA2-62E3-423E-A7C4-DFC791145549
P2860
Underutilisation of ACE inhibitors in patients with congestive heart failure.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Underutilisation of ACE inhibitors in patients with congestive heart failure.
@ast
Underutilisation of ACE inhibitors in patients with congestive heart failure.
@en
Underutilisation of ACE inhibitors in patients with congestive heart failure.
@nl
type
label
Underutilisation of ACE inhibitors in patients with congestive heart failure.
@ast
Underutilisation of ACE inhibitors in patients with congestive heart failure.
@en
Underutilisation of ACE inhibitors in patients with congestive heart failure.
@nl
prefLabel
Underutilisation of ACE inhibitors in patients with congestive heart failure.
@ast
Underutilisation of ACE inhibitors in patients with congestive heart failure.
@en
Underutilisation of ACE inhibitors in patients with congestive heart failure.
@nl
P2093
P1433
P1476
Underutilisation of ACE inhibitors in patients with congestive heart failure.
@en
P2093
Bungard TJ
Johnson JA
McAlister FA
Tsuyuki RT
P304
P356
10.2165/00003495-200161140-00002
P577
2001-01-01T00:00:00Z
P6179
1023041772